搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
11 小时
Strong Prescription Growth and Competitive Advantage Drive Buy Rating for Arcutis ...
Mizuho Securities analyst Uy Ear has maintained their bullish stance on ARQT stock, giving a Buy rating on November 11.Don't Miss our Black ...
Yahoo Finance
14 小时
Concerto Biosciences Announces First Participant Dosed with Live Biotherapeutic ENS-002 in ...
"We are thrilled to have our first participant enrolled," said Chief Executive Officer Cheri Ackerman. "For the millions of people who suffer from atopic dermatitis (AD), or eczema, ENS-002 represents ...
14 小时
Doctor debunks four common eczema myths which are untrue
Therefore, even individuals without childhood eczema may experience it later in life. Dr Grant has debunked the common ...
16 小时
'I'm a doctor - these four common eczema myths are completely untrue'
There are lots of misconceptions around eczema, from poor hygiene to the skin condition disappearing on its own - there is a ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈